                               SEQUENCE LISTING

<110> SAPIENCE THERAPEUTICS, INC.
 
<120> ADMINISTRATION OF CEBP-BETA ANTAGONIST AND METHODS OF USE

<130> SAPIENCE.013.WO1

<140>
<141>

<150> 63/172,560
<151> 2021-04-08

<150> 63/041,991
<151> 2020-06-21

<150> 63/041,990
<151> 2020-06-21

<150> 63/041,989
<151> 2020-06-21

<150> 63/041,988
<151> 2020-06-21

<150> 63/041,986
<151> 2020-06-21

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(22)
<223> D-amino acid

<400> 1
Val Ala Glu Ala Arg Glu Glu Leu Glu Arg Leu Glu Ala Arg Leu Gly 
1               5                   10                  15      


Gln Ala Arg Gly Glu Leu 
            20          


<210> 2
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(38)
<223> D-amino acid

<400> 2
Val Ala Glu Ala Arg Glu Glu Leu Glu Arg Leu Glu Ala Arg Leu Gly 
1               5                   10                  15      


Gln Ala Arg Gly Glu Leu Lys Lys Trp Lys Met Arg Arg Asn Gln Phe 
            20                  25                  30          


Trp Leu Lys Leu Gln Arg 
        35              


<210> 3
<211> 22
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown:
      ATF5 bZIP domain peptide

<400> 3
Leu Glu Gly Glu Cys Gln Gly Leu Glu Ala Arg Asn Arg Glu Leu Lys 
1               5                   10                  15      


Glu Arg Ala Glu Ser Val 
            20          


<210> 4
<211> 22
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown:
      bZIP domain peptide

<400> 4
Leu Glu Gly Arg Ala Gln Gly Leu Arg Ala Glu Leu Arg Glu Leu Glu 
1               5                   10                  15      


Glu Arg Ala Glu Ala Val 
            20          


